Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

[Molecular pathology of sarcomas. Update on the research group "Molecular Diagnosis of Sarcomas"].

Rüsseler AV, Brors B, Fischer T, Hartmann JT, Hartmann W, Hohenberger P, Lichter P, Marx A, Mechtersheimer G, Penzel R, Renner M, Schildhaus HU, Schirmacher P, Sievers E, Ströbel P, Wardelmann E, Ziesché E, Büttner R.

Pathologe. 2010 Oct;31 Suppl 2:211-4. doi: 10.1007/s00292-010-1340-z. German.

PMID:
20711583
2.

Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.

Francis P, Namløs HM, Müller C, Edén P, Fernebro J, Berner JM, Bjerkehagen B, Akerman M, Bendahl PO, Isinger A, Rydholm A, Myklebost O, Nilbert M.

BMC Genomics. 2007 Mar 14;8:73.

3.

Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular aberrations.

Verweij J, Baker LH.

Eur J Cancer. 2010 Mar;46(5):863-8. doi: 10.1016/j.ejca.2010.01.016. Review.

PMID:
20138507
4.

Practical application of molecular genetic testing as an aid to the surgical pathologic diagnosis of sarcomas: a prospective study.

Hill DA, O'Sullivan MJ, Zhu X, Vollmer RT, Humphrey PA, Dehner LP, Pfeifer JD.

Am J Surg Pathol. 2002 Aug;26(8):965-77.

PMID:
12170083
5.

Current soft-tissue sarcoma classifications.

Daugaard S.

Eur J Cancer. 2004 Mar;40(4):543-8.

PMID:
14962721
6.

Expression profiling in soft tissue sarcomas with emphasis on synovial sarcoma, gastrointestinal stromal tumor, and leiomyosarcoma.

West RB.

Adv Anat Pathol. 2010 Sep;17(5):366-73. doi: 10.1097/PAP.0b013e3181ec7428. Review.

PMID:
20733355
7.

Gene expression profiling in sarcomas.

Tschoep K, Kohlmann A, Schlemmer M, Haferlach T, Issels RD.

Crit Rev Oncol Hematol. 2007 Aug;63(2):111-24. Epub 2007 Jun 6. Review.

PMID:
17555981
8.

A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas.

Yu PY, Balkhi MY, Ladner KJ, Alder H, Yu L, Mo X, Kraybill WG, Guttridge DC, Iwenofu OH.

Lab Invest. 2016 Apr;96(4):481-91. doi: 10.1038/labinvest.2015.168. Epub 2016 Feb 15.

9.

Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma.

Nakayama R, Nemoto T, Takahashi H, Ohta T, Kawai A, Seki K, Yoshida T, Toyama Y, Ichikawa H, Hasegawa T.

Mod Pathol. 2007 Jul;20(7):749-59. Epub 2007 Apr 27.

10.

Gene expression profiling of human sarcomas: insights into sarcoma biology.

Baird K, Davis S, Antonescu CR, Harper UL, Walker RL, Chen Y, Glatfelter AA, Duray PH, Meltzer PS.

Cancer Res. 2005 Oct 15;65(20):9226-35.

11.

Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling.

Lee YF, John M, Edwards S, Clark J, Flohr P, Maillard K, Edema M, Baker L, Mangham DC, Grimer R, Wooster R, Thomas JM, Fisher C, Judson I, Cooper CS.

Br J Cancer. 2003 Feb 24;88(4):510-5.

12.

[Medical treatment of soft tissue sarcomas based on the histological subtype].

Pápai Z.

Magy Onkol. 2014 Mar;58(1):53-8. Epub 2014 Feb 1. Review. Hungarian.

13.

MicroRNA profiling of primary high-grade soft tissue sarcomas.

Renner M, Czwan E, Hartmann W, Penzel R, Brors B, Eils R, Wardelmann E, Büttner R, Lichter P, Schirmacher P, Mechtersheimer G.

Genes Chromosomes Cancer. 2012 Nov;51(11):982-96. doi: 10.1002/gcc.21980. Epub 2012 Jul 18.

PMID:
22811003
14.

Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.

Mertens F, Fletcher CD, Dal Cin P, De Wever I, Mandahl N, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van den Berghe H, Vanni R, Willén H.

Genes Chromosomes Cancer. 1998 May;22(1):16-25.

PMID:
9591630
15.

Sarcomas with spindle cell morphology.

Collini P, Sorensen PH, Patel S, Blay JY, Issels RD, Maki RG, Eriksson M, del Muro XG.

Semin Oncol. 2009 Aug;36(4):324-37. doi: 10.1053/j.seminoncol.2009.06.007. Review.

PMID:
19664493
16.

Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.

Ishibe T, Nakayama T, Okamoto T, Aoyama T, Nishijo K, Shibata KR, Shima Y, Nagayama S, Katagiri T, Nakamura Y, Nakamura T, Toguchida J.

Clin Cancer Res. 2005 Apr 1;11(7):2702-12.

17.

Characterization of sarcomas by means of gene expression.

Skubitz KM, Skubitz AP.

J Lab Clin Med. 2004 Aug;144(2):78-91.

PMID:
15322502
18.

A gene expression signature associated with metastatic outcome in human leiomyosarcomas.

Lee YF, John M, Falconer A, Edwards S, Clark J, Flohr P, Roe T, Wang R, Shipley J, Grimer RJ, Mangham DC, Thomas JM, Fisher C, Judson I, Cooper CS.

Cancer Res. 2004 Oct 15;64(20):7201-4.

19.

Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas.

Renner M, Wolf T, Meyer H, Hartmann W, Penzel R, Ulrich A, Lehner B, Hovestadt V, Czwan E, Egerer G, Schmitt T, Alldinger I, Renker EK, Ehemann V, Eils R, Wardelmann E, Büttner R, Lichter P, Brors B, Schirmacher P, Mechtersheimer G.

Genome Biol. 2013 Dec 17;14(12):r137. doi: 10.1186/gb-2013-14-12-r137.

20.

cDNA microarray-based translational research in soft tissue sarcoma.

Lubieniecka JM, Nielsen TO.

J Surg Oncol. 2005 Dec 15;92(4):267-71.

PMID:
16299802

Supplemental Content

Support Center